Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 13 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aprea Therapeutics, Inc. | 80,700 | reported | 12 Mar 2026 | tx 25+6,593,743−604,510 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | GRANT_AWARD | Aprea Therapeutics, Inc. | 20,175 | 0.00 USD | |
| 12 Mar 2026 | GRANT_AWARD | Aprea Therapeutics, Inc. | 80,700 | 0.00 USD | deriv |
| 30 Jan 2026 | PURCHASE | Aprea Therapeutics, Inc. | 28,100 | 0.89 USD | |
| 30 Jan 2026 | PURCHASE | Aprea Therapeutics, Inc. | 28,100 | — | deriv |
| 10 Dec 2025 | PURCHASE | Aprea Therapeutics, Inc. | 21,459 | — | deriv |
| 10 Dec 2025 | PURCHASE | Aprea Therapeutics, Inc. | 21,459 | 1.17 USD | deriv |
| 03 Apr 2025 | PURCHASE | Aprea Therapeutics, Inc. | 2,497 | 1.80 USD | |
| 03 Apr 2025 | PURCHASE | Aprea Therapeutics, Inc. | 3,003 | 1.87 USD | |
| 27 Mar 2025 | GRANT_AWARD | Aprea Therapeutics, Inc. | 6,725 | 0.00 USD | |
| 27 Mar 2025 | GRANT_AWARD | Aprea Therapeutics, Inc. | 26,900 | 0.00 USD | deriv |
| 23 Oct 2024 | PURCHASE | Aprea Therapeutics, Inc. | 500 | 3.92 USD | |
| 15 Oct 2024 | PURCHASE | Aprea Therapeutics, Inc. | 250 | 2.90 USD | |
| 10 Oct 2024 | PURCHASE | Aprea Therapeutics, Inc. | 150 | 2.54 USD | |
| 14 Oct 2024 | PURCHASE | Aprea Therapeutics, Inc. | 1,000 | 2.59 USD | |
| 28 Mar 2024 | GRANT_AWARD | Aprea Therapeutics, Inc. | 6,725 | 0.00 USD | |
| 28 Mar 2024 | GRANT_AWARD | Aprea Therapeutics, Inc. | 26,900 | 0.00 USD | deriv |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 2,000 | 7.29 USD | |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 1,000 | — | deriv |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 1,000 | — | deriv |
| 23 Aug 2022 | CONVERSION | Aprea Therapeutics, Inc. | 6,045,100 | 0.00 USD | |
| 09 Mar 2023 | GRANT_AWARD | Aprea Therapeutics, Inc. | 4,000 | 0.00 USD | |
| 09 Mar 2023 | GRANT_AWARD | Aprea Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 23 Aug 2022 | CONVERSION | Aprea Therapeutics, Inc. | 604,510 | 0.00 USD | deriv |
| 28 Jul 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 101,300 | 0.00 USD | |
| 28 Jul 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 148,700 | 0.00 USD | deriv |